General Information of the Compound
Compound ID |
CP0030279
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(5Z,8Z)-Icosa-5,8,11,14-tetraenoic acid (4-hydroxy-phenyl)-amide
Show/Hide
|
||||||||||||||||||
Synonyms |
(5Z,8Z,11Z,14Z)-N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide
183718-77-6
198022-70-7
5,8,11,14-Eicosatetraenamide, N-(4-hydroxyphenyl)-, (all-Z)-
AC1O7GXA
AM 404
AM-404
CHEMBL39878
CPD000449274
N-(4-Hydroxyphenyl)-arachidonylamide
N-(4-Hydroxyphenyl)arachidonoyl amide
N-(4-Hydroxyphenyl)arachidonylamide
N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide
N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide
NCGC00025010-01
SMR000449274
SR-01000597390
Tocris-1116
UNII-XVJ94H0U21
XVJ94H0U21
am404
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C26H37NO2
|
||||||||||||||||||
Molecular Weight |
395.587
|
||||||||||||||||||
Canonical SMILES |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)Nc1ccc(O)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C26H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-26(29)27-24-20-22-25(28)23-21-24/h6-7,9-10,12-13,15-16,20-23,28H,2-5,8,11,14,17-19H2,1H3,(H,27,29)/b7-6-,10-9-,13-12-,16-15-
Show/Hide
|
||||||||||||||||||
InChIKey |
IJBZOOZRAXHERC-DOFZRALJSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound